Long-term Chemotherapy for Advanced NSCLC

被引：0
|
作者：
Matsuura, Y. [1 ]
Hirashima, T. [1 ]
Suzuki, H. [1 ]
Kobayashi, M. [1 ]
Tamiya, M. [1 ]
Morishita, N. [1 ]
Sasada, S. [1 ]
Okamoto, N. [1 ]
Akagawa, K. [2 ]
Kawase, I. [3 ]
机构：
[1] Osaka Prefectural Hosp Org, Osaka Prefectural Med Ctr, Habikino, Japan
[2] Niigata Univ, Med & Dent Hosp, Niigata, Japan
[3] Osaka Prefectural Med Ctr Resp & Allerg Dis, Habikino, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72422-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S625 / S625
页数：1
相关论文
共 50 条
  • [1] Pneumonectomy after chemotherapy in NSCLC: Early and long-term results
    Maietta, Pierpaolo
    Massimo, Mario
    Maiorino, Alfonso
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S33 - S33
  • [2] Long-term results of chemotherapy in advanced thyroid carcinoma
    Bueso, P
    Isla, D
    Mayordomo, JI
    Alonso, M
    Herraez, J
    Cajal, R
    Yubero, A
    Escudero, P
    Saenz, A
    Tres, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 865 - 865
  • [3] Long-Term Results of Adjuvant Chemotherapy in Completely Resected NSCLC Patients
    Wurstbauer, Karl
    Sedlmayer, Felix
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (07) : 404 - 405
  • [4] CIMAvax-EGF: Toward long-term survival of advanced NSCLC
    Crombet, T.
    Saavedra, D.
    Neninger, E.
    Rodriguez, C.
    Viada, C.
    Mazorra, Z.
    Dy, G.
    Lee, K.
    Groman, A.
    Lage, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1646 - 1647
  • [5] Long-term survivors with immunotherapy in advanced NSCLC: is 'cure' within reach?
    Monteverdi, Sara
    Vita, Emanuele
    Sartori, Giulia
    Ferrara, Miriam Grazia
    D'Argento, Ettore
    Tortora, Giampaolo
    Milella, Michele
    Bria, Emilio
    Pilotto, Sara
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (02) : 409 - 414
  • [6] CIMAvax-EGF: Toward long-term survival of advanced NSCLC
    Saavedra, Danay
    Neninger, Elia
    Rodriguez, Camilo
    Viada, Carmen
    Mazorra, Zaima
    Lage, Agustin
    Crombet, Tania
    SEMINARS IN ONCOLOGY, 2018, 45 (1-2) : 34 - 40
  • [7] Long-Term Safety and Efficacy of Darbepoetin Alfa in Subjects with Advanced Stage NSCLC Receiving Multi-Cycle Chemotherapy
    Gage, Julia
    Gascon, Pere
    Nagarkar, Rajnish
    Smakal, Martin
    Syrigos, Kostas
    Barrios, Carlos
    Cardenas Sanchez, Jesus
    Zhang, Li
    Henry, David
    Fleishman, Alex
    Brandao, Cisio De Oliveira
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1091 - S1092
  • [8] Long-Term Safety and Efficacy of Darbepoetin Alfa in Subjects With Advanced Stage NSCLC Receiving Multi-Cycle Chemotherapy
    Gascon, Pere
    Nagarkar, Rajnish
    Smakal, Martin
    Syrigos, Kostas
    Barrios, Carlos H.
    Cardenas Sanchez, Jesus
    Zhang, Li
    Henry, David H.
    Fleishman, Alex
    Brandao, Cisio De Oliveira
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S214 - S215
  • [9] Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
    Schwartz, PE
    Rutherford, TJ
    Chambers, JT
    Kohorn, EI
    Thiel, RP
    GYNECOLOGIC ONCOLOGY, 1999, 72 (01) : 93 - 99
  • [10] Which advanced-stage NSCLC patients attain long-term survival?
    Wang, Tina J.
    Bogardus, Alicia
    Nelson, Rebecca
    Grannis, Frederic
    CHEST, 2007, 132 (04) : 589S - 590S
12345